GLUE

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Monte Rosa Therapeutics Inc

NASDAQ | GLUE

16.17

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$1.04B

Market Cap

49.97

P/E Ratio

0.32

EPS

$16.66

52 Week High

$3.50

52 Week Low

HEALTHCARE

Sector

GLUE Chart

Recent Chart
Price Action

GLUE Technicals

Tags:

GLUE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $68M
Total Revenue $76M
Cost Of Revenue $8.1M
Costof Goods And Services Sold $8.1M
Operating Income -$81M
Selling General And Administrative $35M
Research And Development $122M
Operating Expenses $149M
Investment Income Net -
Net Interest Income $11M
Interest Income $11M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.1M
Income Before Tax -$70M
Income Tax Expense $2.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$73M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$73M
Net Income -$73M

Revenue & Profitability

Earnings Performance

GLUE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $439M
Total Current Assets $377M
Cash And Cash Equivalents At Carrying Value $224M
Cash And Short Term Investments $224M
Inventory -
Current Net Receivables $173K
Total Non Current Assets $61M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $148M
Other Current Assets $5.1M
Other Non Current Assets -
Total Liabilities $216M
Total Current Liabilities $157M
Current Accounts Payable $17M
Deferred Revenue -
Current Debt -
Short Term Debt $3.7M
Total Non Current Liabilities $59M
Capital Lease Obligations $43M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $43M
Other Current Liabilities $19M
Other Non Current Liabilities -
Total Shareholder Equity $223M
Treasury Stock -
Retained Earnings -$439M
Common Stock $6K
Common Stock Shares Outstanding $74M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $42M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.1M
Capital Expenditures $4M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$44M
Cashflow From Financing $99M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$641K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$73M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $68M
Total Revenue $76M
Cost Of Revenue $8.1M
Costof Goods And Services Sold $8.1M
Operating Income -$81M
Selling General And Administrative $35M
Research And Development $122M
Operating Expenses $149M
Investment Income Net -
Net Interest Income $11M
Interest Income $11M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.1M
Income Before Tax -$70M
Income Tax Expense $2.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$73M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$73M
Net Income -$73M

GLUE News

GLUE Profile

Monte Rosa Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Monte Rosa Therapeutics, Inc. (GLUE) is a pioneering biopharmaceutical company based in Boston, Massachusetts, focused on developing precision small molecule therapeutics that harness the body's inherent mechanisms for targeted protein degradation. Leveraging its proprietary technology platforms, Monte Rosa aims to address critical unmet medical needs across various therapeutic areas, notably in oncology and autoimmune diseases. With a robust pipeline of innovative drug candidates and a steadfast commitment to scientific excellence, the company is strategically positioned to transform treatment modalities and enhance patient outcomes through its groundbreaking approaches to drug discovery.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+51.88%
$1.61
VINE
+10.76%
$0.39
NVDA
-1.80%
$177.00
AMZE
+23.68%
$0.48
TLRY
-22.27%
$0.80
IPG
-1.95%
$24.57
BITF
+10.80%
$3.43
INTC
+9.08%
$40.15
AXDX
-61.36%
$0.03
YGMZ
-10.16%
$0.11
TSLA
+1.71%
$426.58
BYND
-4.59%
$0.97
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
KVUE
+1.11%
$17.22
RUBI
-26.31%
$0.15
CLSK
+11.97%
$15.06
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BMNR
+3.76%
$32.93
PLUG
+2.27%
$2.02
BIYA
+10.67%
$0.27
INHD
-0.79%
$0.22
SRM
+53.27%
$10.30
CHR
-2.55%
$0.04
ONMD
+31.69%
$1.87
SNAP
+0.37%
$7.63
WULF
+4.51%
$15.51
TWOH
0.00%
$0.00
BMNU
+3.72%
$7.79
CIFR
+7.41%
$20.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AAL
+0.72%
$14.03
MARA
+4.18%
$11.57
VALE
+0.79%
$12.61
ONDS
-4.36%
$7.88
SOFI
+4.31%
$29.72
GPUS
-9.06%
$0.30
NIO
+1.09%
$5.51
F
+0.61%
$13.27
AFMD
-34.94%
$0.18
DEFT
+9.24%
$1.51
BURU
+7.72%
$0.22
APLD
+5.05%
$24.94
BTBT
+1.15%
$2.34
KWM
+17.30%
$0.77
GOOGL
-0.26%
$319.09
SMX
+244.97%
$60.02
AMZN
+1.77%
$233.22
CRCL
+9.28%
$79.38
BTG
+3.25%
$4.61
GRYP
-10.38%
$1.38
DVLT
-7.05%
$1.97
HBI
-2.20%
$6.44
ACHR
+4.79%
$7.84
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
IBRX
+9.15%
$2.32
CAN
+10.07%
$1.01
GRAB
+2.34%
$5.44
RIOT
+6.97%
$16.00
IREN
-1.31%
$47.81
AG
+12.47%
$15.19
NGD
+5.92%
$8.30
KDLY
+7.20%
$0.49
DNN
+0.39%
$2.57
VEEE
+50.56%
$2.68
YCBD
-3.44%
$0.53
CRCA
+17.43%
$4.32
AMC
+5.99%
$2.43
TMC
+17.92%
$6.87
GOOG
-0.34%
$319.17
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
RIG
+1.97%
$4.38
PFE
+0.05%
$25.72
SHOT
-74.37%
$0.39
NVO
+1.56%
$49.47
RIVN
+4.82%
$16.96
ZAPP
-46.30%
$0.15
AGNC
-0.80%
$10.47
CDE
+6.08%
$17.17
SMR
+4.38%
$19.87
SNDK
+3.83%
$223.28
MSTR
+0.01%
$175.66
WBD
+0.94%
$24.10
BTE
+2.84%
$3.25
ITUB
+2.02%
$7.81
EXK
+15.28%
$9.93
BAC
+1.26%
$53.65
HL
+4.56%
$16.69
PLTR
+0.80%
$167.11
NOK
0.00%
$6.08
ABVE
+12.77%
$2.96
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+51.88%
$1.61
VINE
+10.76%
$0.39
NVDA
-1.80%
$177.00
AMZE
+23.68%
$0.48
TLRY
-22.27%
$0.80
IPG
-1.95%
$24.57
BITF
+10.80%
$3.43
INTC
+9.08%
$40.15
AXDX
-61.36%
$0.03
YGMZ
-10.16%
$0.11
TSLA
+1.71%
$426.58
BYND
-4.59%
$0.97
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
KVUE
+1.11%
$17.22
RUBI
-26.31%
$0.15
CLSK
+11.97%
$15.06
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
BMNR
+3.76%
$32.93
PLUG
+2.27%
$2.02
BIYA
+10.67%
$0.27
INHD
-0.79%
$0.22
SRM
+53.27%
$10.30
CHR
-2.55%
$0.04
ONMD
+31.69%
$1.87
SNAP
+0.37%
$7.63
WULF
+4.51%
$15.51
TWOH
0.00%
$0.00
BMNU
+3.72%
$7.79
CIFR
+7.41%
$20.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AAL
+0.72%
$14.03
MARA
+4.18%
$11.57
VALE
+0.79%
$12.61
ONDS
-4.36%
$7.88
SOFI
+4.31%
$29.72
GPUS
-9.06%
$0.30
NIO
+1.09%
$5.51
F
+0.61%
$13.27
AFMD
-34.94%
$0.18
DEFT
+9.24%
$1.51
BURU
+7.72%
$0.22
APLD
+5.05%
$24.94
BTBT
+1.15%
$2.34
KWM
+17.30%
$0.77
GOOGL
-0.26%
$319.09
SMX
+244.97%
$60.02
AMZN
+1.77%
$233.22
CRCL
+9.28%
$79.38
BTG
+3.25%
$4.61
GRYP
-10.38%
$1.38
DVLT
-7.05%
$1.97
HBI
-2.20%
$6.44
ACHR
+4.79%
$7.84
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
IBRX
+9.15%
$2.32
CAN
+10.07%
$1.01
GRAB
+2.34%
$5.44
RIOT
+6.97%
$16.00
IREN
-1.31%
$47.81
AG
+12.47%
$15.19
NGD
+5.92%
$8.30
KDLY
+7.20%
$0.49
DNN
+0.39%
$2.57
VEEE
+50.56%
$2.68
YCBD
-3.44%
$0.53
CRCA
+17.43%
$4.32
AMC
+5.99%
$2.43
TMC
+17.92%
$6.87
GOOG
-0.34%
$319.17
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
RIG
+1.97%
$4.38
PFE
+0.05%
$25.72
SHOT
-74.37%
$0.39
NVO
+1.56%
$49.47
RIVN
+4.82%
$16.96
ZAPP
-46.30%
$0.15
AGNC
-0.80%
$10.47
CDE
+6.08%
$17.17
SMR
+4.38%
$19.87
SNDK
+3.83%
$223.28
MSTR
+0.01%
$175.66
WBD
+0.94%
$24.10
BTE
+2.84%
$3.25
ITUB
+2.02%
$7.81
EXK
+15.28%
$9.93
BAC
+1.26%
$53.65
HL
+4.56%
$16.69
PLTR
+0.80%
$167.11
NOK
0.00%
$6.08
ABVE
+12.77%
$2.96
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.